Inventor
KOU BUYU
CN10 patents
Patents
10 patentsUS9233978B2Jan 12, 2016
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE18 citations91
US10428069B2Oct 1, 2019
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE6 citations83
US10081627B2Sep 25, 2018
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE9 citations83
US9890167B2Feb 13, 2018
Pyrazine compounds for the treatment of infectious diseases
HOFFMANN LA ROCHE4 citations72
US9758530B2Sep 12, 2017
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE3 citations71
US9266904B2Feb 23, 2016
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE5 citations71
US11713327B2Aug 1, 2023
Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE1 citations62
US12351575B2Jul 8, 2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations61
US11168086B2Nov 9, 2021
Methods of synthesizing pyrazine compounds
HOFFMANN LA ROCHE0 citations61
US10562905B2Feb 18, 2020
Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseases
HOFFMANN LA ROCHE1 citations61